PharmaCyte Biotech, Inc. (PMCB)
Biological Products, (No Diagnostic Substances) · Healthcare · $685M
Intrinsic Value (Consensus)
$37.80
Current Price
$63.80
Margin of Safety
-40.8%
40.8% Above Intrinsic Value
Value: $38
Price: $64
Valuation Model Estimates
Current Price: $63.80
DCF (Discounted Cash Flow)
Not applicable
—
Graham Number
$18.63
Earnings Power Value
$30.97
Relative Value (P/E)
$63.80
Dividend Discount Model
Not applicable
—
Consensus Value
$37.80
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Key Financials
- EPS (TTM)
- $3.19
- EPS (Forward)
- $3.35
- Book Value
- $4.83
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- 59.1%
- Debt/Equity
- 0%
- Revenue Growth
- N/A
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Data last updated: 2026-06-12
Source: Yahoo Finance